NCT07004465View on ClinicalTrials.gov

Effectiveness of Vitamin b12 Versus Kenalog on Traumatic Ulcer Associated With Orthodontic Treatment

NANot yet recruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

August 19, 2025

Primary Completion Date

December 19, 2025

Study Completion Date

January 19, 2026

Conditions

Mouth Ulcer

Interventions

DIETARY_SUPPLEMENT

cyanocobalamin

Group A will be given vitamin B12 tablets (1000 mcg) once daily.

DEVICE

triamcinolone acetonide

Group B will be given Kenalog gel (triamcinolone acetonide 40 mg/ml). The other ingredients are benzyl alcohol, polysorbate 80, carmellose sodium, sodium chloride and water, by covering the area twice daily

Trial Locations (1)

56001

Karbala university, Karbala

All Listed Sponsors

lead

Hawraa Ali Abdullah

OTHER

NCT07004465 - Effectiveness of Vitamin b12 Versus Kenalog on Traumatic Ulcer Associated With Orthodontic Treatment | Biotech Hunter | Biotech Hunter